Precision BioSciences, Inc. Common Stock (DTIL) is a publicly traded Healthcare sector company. As of September 30, 2026, DTIL trades at $6.29 with a market cap of $172.23M and a P/E ratio of -4.85. DTIL moved +0.57% today. Year to date, DTIL is +48.56%; over the trailing twelve months it is +21.41%. Its 52-week range spans $3.53 to $9.62. Analyst consensus is buy with an average price target of $60.00. Rallies surfaces DTIL's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks hedge fund and 13F ownership for DTIL, including fund holders, share counts, and position changes when data is available.
| Metric | Value |
|---|---|
| Price | $6.29 |
| Market Cap | $172.23M |
| P/E Ratio | -4.85 |
| EPS | $-1.28 |
| Dividend Yield | 0.00% |
| 52-Week High | $9.62 |
| 52-Week Low | $3.53 |
| Volume | 28.87K |
| Avg Volume | 0 |
| Revenue (TTM) | $45.05M |
| Net Income | $-52.73M |
| Gross Margin | 0.00% |
1 analysts cover DTIL: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $60.00.